Hillsdale Investment Management Inc. Gilead Sciences, Inc. Transaction History

Hillsdale Investment Management Inc.

  • $1.13 Billion
  • Q1 2024

A detailed history of Hillsdale Investment Management Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 160 shares of GILD stock, worth $10,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares
160
Previous 160 -0.0%
Holding current value
$10,944
Previous $12,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$73.27 - $83.09 $29,601 - $33,568
-404 Reduced 71.63%
160 $12,000
Q3 2023

Nov 09, 2023
SELL
$73.94 - $80.67 $578,654 - $631,323
-7,826 Reduced 93.28%
564 $42,000
Q2 2023

Aug 11, 2023
BUY
$76.01 - $86.7 $34,964 - $39,882
460 Added 5.8%
8,390 $646,000
Q1 2023

May 10, 2023
BUY
$77.31 - $88.08 $126,015 - $143,570
1,630 Added 25.87%
7,930 $657,000
Q4 2022

Feb 13, 2023
SELL
$62.32 - $89.47 $137,104 - $196,834
-2,200 Reduced 25.88%
6,300 $540,000
Q2 2022

Aug 12, 2022
BUY
$57.72 - $65.01 $490,620 - $552,585
8,500 New
8,500 $525,000
Q3 2021

Oct 21, 2021
SELL
$67.69 - $73.03 $6,430 - $6,937
-95 Closed
0 $0
Q2 2021

Jul 29, 2021
SELL
$63.47 - $69.35 $410,968 - $449,041
-6,475 Reduced 98.55%
95 $7,000
Q1 2021

Apr 22, 2021
BUY
$60.0 - $68.46 $6,000 - $6,845
100 Added 1.55%
6,570 $425,000
Q4 2020

Feb 09, 2021
SELL
$56.65 - $64.55 $30,024 - $34,211
-530 Reduced 7.57%
6,470 $377,000
Q1 2020

May 12, 2020
SELL
$62.63 - $80.22 $69,206 - $88,643
-1,105 Reduced 13.63%
7,000 $524,000
Q4 2019

Feb 12, 2020
BUY
$61.62 - $67.78 $12,324 - $13,556
200 Added 2.53%
8,105 $526,000
Q3 2019

Nov 13, 2019
BUY
$62.51 - $69.0 $20,940 - $23,115
335 Added 4.43%
7,905 $501,000
Q2 2019

Aug 02, 2019
BUY
$61.87 - $69.38 $55,683 - $62,441
900 Added 13.49%
7,570 $512,000
Q1 2019

May 13, 2019
BUY
$62.53 - $70.05 $130,062 - $145,704
2,080 Added 45.32%
6,670 $434,000
Q4 2018

Feb 12, 2019
SELL
$60.54 - $79.0 $42,378 - $55,300
-700 Reduced 13.23%
4,590 $287,000
Q2 2018

Aug 13, 2018
SELL
$64.88 - $75.68 $1,297 - $1,513
-20 Reduced 0.38%
5,290 $375,000
Q1 2018

May 14, 2018
SELL
$72.84 - $88.8 $14,568 - $17,760
-200 Reduced 3.63%
5,310 $400,000
Q3 2017

Nov 13, 2017
BUY
$72.11 - $85.47 $50,477 - $59,829
700 Added 14.55%
5,510 $447,000
Q2 2017

Aug 14, 2017
BUY
N/A
4,810
4,810 $341,000

Others Institutions Holding GILD

# of Institutions
1,885
Shares Held
1B
Call Options Held
8.71M
Put Options Held
8.02M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $85.7B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email